News

Vaccination rates in the U.S. continue to lag, and new research presented at IDWeek 2024 in Los Angeles, California, underscored the role social vulnerabilities play in access to preventive healthcare.

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Use of pre-exposure prophylaxis (PrEP), an HIV-1 prevention strategy, across diverse demographic groups is not consistent, despite importance of the tool.

New data presented at IDWeek 2024, October 16-19, alerted doctors about the national trends and racial disparities in sepsis-related mortality rates (SRMR) in children between 1999 to 20219.

Hot and cold outdoor temperatures significantly worsen Raynaud’s phenomenon in patients with systemic sclerosis, according to new research.

New research presented at IDWeek 2024 may impact advice patients are given on how long antibiotics take to work following treatment of bloodstream infections.

A major randomized clinical trial has demonstrated that home-based narrowband UV-B phototherapy is as effective as office-based treatment for patients with plaque or guttate psoriasis.

Avian influenza H5 was detected in municipal wastewater solids during a U.S. cattle outbreak, providing a potential early warning system for future outbreaks.